纳豆激酶的分离纯化研究

从实验室保存的一株高产纳豆激酶菌株出发,进行发酵产酶,确立具有纤溶活力的纳豆激酶的分离纯化工艺,主要通过硫酸铵分级盐析法和Phenyl Sepharose疏水柱层析进行分离纯化,用纤维蛋白平板法测定酶活力,用SDS-PAGE电泳验证为电泳纯,分子量为28kD。其有望开发为新型的口服溶栓药物。     

药食两用纳豆激酶的研究进展

本文从血栓栓塞疾病的形成机制为依据,综述了纳豆激酶的药理作用。介绍了国内外产纤溶酶菌株的筛选方法,纳豆激酶的分离、纯化常用技术,纳豆激酶的生理生化特性、活性测定方法。并说明了影响纳豆激酶稳定的4个因素,和增加纳豆激酶产量的有效方法。通过药食两用纳豆激酶的研究进展,希望对纳豆激酶的研究提供理论基础。     

纳豆激酶的研究与应用

纳豆激酶是一种枯草芽孢杆菌产生的丝氨酸蛋白酶 ,具有强烈的纤溶活性 ,有望开发成为新型口服溶栓药。综述了纳豆激酶的生化特性、生物学活性、结构与功能及开发应用前景等。     

纳豆激酶的分离纯化及生化研究

用固体发酵工艺制得的纳豆中含有大量溶栓活性成分———纳豆激酶。经过生理盐水浸提 ,(NH4 ) 2 SO4 分级沉淀 ,Sephadex柱层析等步骤 ,可以得一层析纯的纳豆激酶。冷冻干燥品经SDS—PAGE电泳显示有二组分存在     

纳豆激酶的发酵工艺研究

以实验室选育的纳豆菌— 6号 (Bacillusnatto 6)为出发菌株 ,研究其固液两种发酵条件对纳豆激酶溶栓活力的影响。研究表明 ,纳豆菌适于固体发酵 ,37℃下 2 4h ,其活力可达 1 60 0IU/g以上。     

纳豆激酶的研究现状与展望

纳豆激酶是从日本传统食品纳豆中提取的一种枯草杆菌蛋白酶,具有高效的抗血栓作用.与其他传统溶栓剂相比,纳豆激酶具有安全性好、成本低、易被人体吸收、作用直接迅速、作用持续时间长等优点,因此极有可能开发为新一代的溶栓剂.概括了纳豆激酶的分子结构、理化性质、溶栓作用机理、活性检测方法,介绍了其分子生物学研究进展,并对其开发应用进行了展望,证明纳豆激酶具有广阔的市场应用前景.     

纳豆激酶液态发酵条件的研究

考察纳豆杆菌在7.5 L发酵罐中分批发酵产纳豆激酶的条件,纳豆激酶酶活采用四肽底物测定。结果表明:纳豆杆菌生长和产酶的适宜条件不一致。发酵过程中发酵罐搅拌转速控制为500 r/min不变,0～12 h时控制pH为8.0、温度为37℃;12～36 h调整pH为7.0、温度为30℃;16 h时补加外源C源,连续发酵36 h。该过程中发酵液中比酶活最高达到3 232 U/mL,与摇瓶发酵相比,比酶活提高了58%。     

影响纳豆激酶酶促反应速度因素的研究

利用分光光度法对由纳豆菌发酵产生的纳豆激酶 (NK)进行了动力学性质的研究。以双倒数作图法 (L -B作图法 )求取Km。采用单因素试验法和正交试验法研究了底物浓度、酶浓度、温度、pH值对酶促反应速度的影响。结果表明该纳豆激酶的Km值为 3.4 98× 1 0 -6g·mL-1 ,当水解时间为 1 0min时 ,最适底物浓度为 1 6mg·mL-1 ,最适温度为 6 0℃ ,最适 pH为 8.0。     

纳豆激酶生产菌的筛选及发酵纳豆特性研究

为开发具有特定生理活性的新型纳豆保健品,从发酵豆制品中分离筛选得到一株纳豆激酶高产菌株。利用该菌株以及市售的3种纳豆中的纳豆菌进行纳豆发酵,比较了4株纳豆菌发酵纳豆的特性,并对纳豆激酶活性进行分析。结果表明5号菌株发酵生产纳豆周期短,颜色金黄,具有酱香味,拉丝长度最佳。同时,对产纳豆激酶的最佳发酵时间进行研究,结果表明发酵至17 h纳豆激酶活性达到最大值。     

The "lazy" NK cells of Chediak-Higashi syndrome

Natural killer (NK) function, measured in a short-term (4-hr) 51Cr-release assay, is profoundly depressed in circulating PBL of donors with Chediak-Higashi syndrome (CHS). In this study, we demonstrate that CHS NK cells can express relatively normal lytic function after prolonged exposure in vitro to high levels of activating as well as cytotoxic stimuli. After activation with the human cloned interferon (B1) for 24 hr, CHS NK cells have lytic activity comparable to unactivated normals in a 4-hr 51Cr-release assay. In addition, after 5 days of activation with mitomycin C-treated B cell lines, CHS NK cells have levels of activity similar to those of activated normals but are defective in generating cytotoxic cells capable of lysing the stimulator B cell. Even though CHS NK cells are defective in a 4-hr 51Cr-release assay, after 16 hr they enhance their killing capability 200 to 400-fold. In fact, after 16 hr of interaction with K562 target cells, CHS NK cells are capable of releasing NK soluble cytotoxic factors. These results are consistent with the hypothesis that CHS NK cells have all the necessary cellular structures and molecules required for them to function as lytic effector cells, but their lack of cytotoxic function is due to a relative refractoriness in initiating the post-binding lytic mechanism.     

CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation

Human NK cells comprise two main subsets, CD56(bright) and CD56(dim) cells, which differ in function, phenotype, and tissue localization. To further dissect the differentiation from CD56(bright) to CD56(dim) cells, we performed ex vivo and in vitro experiments demonstrating that the CD56(bright)CD16(+) cells are an intermediate stage of NK cell maturation. We observed that the maximal frequency of the CD56(bright)CD16(+) subset among NK cells, following unrelated cord blood transplantation, occurs later than this of the CD56(bright)CD16(-) subset. We next performed an extensive phenotypic and functional analysis of CD56(bright)CD16(+) cells in healthy donors, which displayed a phenotypic intermediary profile between CD56(bright)CD16(-) and CD56(dim)CD16(+) NK cells. We also demonstrated that CD56(bright)CD16(+) NK cells were fully able to kill target cells, both by Ab-dependent cell cytotoxicity (ADCC) and direct lysis, as compared with CD56(bright)CD16(-) cells. Importantly, in vitro differentiation experiments revealed that autologous T cells specifically encourage the differentiation from CD56(bright)CD16(-) to CD56(bright)CD16(+) cells. Finally, further investigations performed in elderly patients clearly showed that both CD56(bright)CD16(+) and CD56(dim)CD16(+) mature subsets were substantially increased in older individuals, whereas the CD56(bright)CD16(-) precursor subset was decreased. Altogether, these data provide evidence that the CD56(bright)CD16(+) NK cell subset is a functional intermediate between the CD56(bright) and CD56(dim) cells and is generated in the presence of autologous T CD3(+) cells.     

Formation of intermediate products in the reaction of hemoglobin with cyanide

Interaction between methemoglobin and cyanide was studied by low temperature inhibition method in combination with ESR. A new, not earlier described in literature ESR signal of low spin cyanide complex of this protein was recorded.     

The "intermediate component" of the radiosodium efflux from frog skeletal muscle

The influence of diversity in the size of the cells of the frog's sartorius on the radiosodium efflux from the muscle was investigated. Morphometric analyses of light micrographs of complete cross sections of the muscle were done in the proximal and distal regions. The results were used to predict the shape of the radiosodium washout curve under the following assumptions: the cells differ in size and shape, but each has a single internal pool of exchangeable sodium; the sodium exchange properties of the limiting membranes are the same for all cells; and the diversity of the true areas of the limiting membranes is reflected by the diversity of the apparent areas measured at the light microscopic level. Radiosodium efflux measurements were performed on similar muscles. The model correctly predicted the occurrence of a continuous decline of the fractional loss of radiosodium, which was not due to diffusional delay and which would be interpreted as a second internal compartment in a compartmental analysis, and an effect of short versus long isotope loading intervals on the efflux. It was concluded that the existence of cell size diversity satisfactorily explains the flux data. No "special region" must be postulated.     

重组细胞因子制品热原质试验中的降温现象

中国生物制品规程规定采用家兔试验法进行热原试验。规程要求当家兔降温≥０６℃或２只及２只以上降温在０４～０６℃时应重试。在４２０批各类细胞因子热原质试验中发现２３批出现降温,重试后合格率为１００％。降温原因分析表明降温现象与热原性物质无关,与制品种类不存在显著相关性。因此,热原试验中出现家兔降温时是否需要重试值得商榷